A Psychedelic Breakthrough In the Treatment of Trauma and Addiction | Dr. Nolan Williams

Stanford University’s Dr. Nolan Williams is one of the world’s leading researchers on psychedelic medicine. He joined Rep. Crenshaw to talk about the revolutionary clinical trial he recently conducted with the psychedelic ibogaine to treat veterans suffering from PTSD, Traumatic Brain Industry, and addiction. The clinical trial showed a phenomenal 83% remission rate for participants after just one treatment. Dr. Williams explains what ibogaine is, the experiences patients have while taking it, what we know about how it affects the brain, and how it differs from classic psychedelics like MDMA and psylocibin. They also discuss the potential for ibogaine treatments to combat America’s addiction epidemic. Nolan Williams, MD, is an Associate Professor of neurology and psychiatry at Stanford University and the Director of the Stanford Brain Stimulation Lab. He is one of leading researchers in the study of how psychedelics can impact the human brain and be used to successfully treat various health challenges such as post-traumatic stress disorder, traumatic brain injury, and major depression. Read his study in Nature Medicine: https://www.nature.com/articles/s41591-023-02705-w and follow him on X at @NolanRyWilliams.